Calcium Gluc 100mg/ml Inj, 100ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.
In the event that you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
Lifestyle & Tips
- This medication is typically administered in a hospital or clinic setting by a healthcare professional.
- Report any discomfort or pain at the injection site immediately.
- Inform your doctor about all other medications you are taking, especially heart medications like digoxin.
Available Forms & Alternatives
Available Strengths:
- Calcium Carb 1250mg/5ml Susp
- Calcium Chloride 10% Inj, 10ml
- Calcium Oyster Shell 500mg Tablets
- Calcium 500mg Tablets
- Calcium Acetate 667mg Capsules
- Calcium 600+d (400u) Tablets
- Calcium 600mg Tablets
- Calcium 600mg + D Tablets
- Calcium 500 W/vit D3 Tablets
- Calcium Citrate 250mg Tablets
- Calcium Antacid 500mg Chw Tablets
- Calcium Carb 500mg Chewtablets
- Calcium Acetate 667mg Tablets
- Calcium Carb 648mg Tablets
- Calcium 500mg W/ Vit D Chw Tablets
- Calcium Citrate W/ Vit D Tablets
- Calcium/d3 600mg-200iu Tablets
- Calcium 500mg Chewable Tablets
- Calcium Gluconate 10% Inj, 50ml
- Calcium Antacid 750mg Chw Tablets
- Calcium Citrate 200mg Tablets
- Calcium Citrate+d3 Tablets
- Calcium Gluconate 10% Inj, 10ml
- Calcium Glu/nacl 1gm/100ml Soln
- Cal Glu/nacl 2000mg/100ml Inj 100ml
- Cal Glu/nacl 1gm/50ml Inj, 50ml
- Calcium Gluc 100mg/ml Inj, 50ml
- Calcium Gluconate 10% Inj, 100ml
- Calcium Gluc 100mg/ml Inj, 100ml
- Calcium Gluc 100mg/ml Inj, 10ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high calcium levels, including:
+ Weakness
+ Confusion
+ Feeling tired
+ Headache
+ Upset stomach and vomiting
+ Constipation
+ Bone pain
Symptoms that may occur if the medication is administered too quickly, such as:
+ Flushing
+ Slow or abnormal heartbeat
+ Signs of low blood pressure, including severe dizziness or fainting
Tissue damage at the injection site, characterized by:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid
If you experience any of these symptoms, notify your doctor or nurse immediately.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, or if they persist or bother you, contact your doctor:
* Constipation
This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Nausea or vomiting
- Constipation
- Increased thirst or urination
- Muscle weakness or fatigue
- Confusion or drowsiness
- Irregular heartbeat
- Pain, swelling, or redness at the injection site
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have high calcium levels in your blood.
* If you are currently taking ceftriaxone or digoxin.
Please note that this is not an exhaustive list of potential interactions. To ensure your safety, it is crucial to discuss all of your medications (including prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions.
Remember, do not start, stop, or change the dose of any medication without first consulting your doctor. This will help prevent potential interactions and ensure your safety while taking this medication.
Precautions & Cautions
Additionally, this medication may contain aluminum, which can increase the risk of aluminum toxicity with long-term use. This risk is particularly higher if you have kidney problems or if you are a premature infant. It is vital to discuss this potential risk with your doctor.
If you are pregnant, planning to become pregnant, or breastfeeding, you must consult your doctor to weigh the benefits and risks of taking this medication to ensure the best possible outcome for you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypercalcemia (calcium levels too high)
- Nausea, vomiting, constipation
- Polyuria, polydipsia
- Muscle weakness, lethargy, confusion, stupor, coma
- Cardiac arrhythmias (bradycardia, heart block)
- Hypotension
- Renal dysfunction
What to Do:
Immediate discontinuation of calcium gluconate. Treatment involves hydration with normal saline, loop diuretics (e.g., furosemide) to promote calcium excretion, and potentially calcitonin or bisphosphonates in severe cases. Close monitoring of serum calcium, electrolytes, renal function, and ECG is essential. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.
Drug Interactions
Contraindicated Interactions
- Digoxin (concurrent IV administration, especially with rapid infusion, can precipitate severe arrhythmias due to synergistic effects on cardiac contractility and excitability. If calcium is essential, administer slowly with continuous ECG monitoring and only if hypocalcemia is severe and life-threatening.)
Major Interactions
- Thiazide diuretics (may decrease calcium excretion, leading to hypercalcemia)
- Phosphates (IV administration can lead to precipitation of calcium phosphate)
- Bicarbonates (IV administration can lead to precipitation of calcium carbonate)
- Calcium channel blockers (calcium may antagonize the effects of calcium channel blockers)
Moderate Interactions
- Tetracyclines (oral calcium can chelate tetracyclines, reducing absorption; not relevant for IV calcium gluconate)
- Fluoroquinolones (oral calcium can chelate fluoroquinolones, reducing absorption; not relevant for IV calcium gluconate)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide dosing, especially in hypocalcemia.
Timing: Prior to administration
Rationale: To assess cardiac rhythm and identify signs of hyperkalemia or digoxin toxicity, and to monitor for adverse cardiac effects during infusion.
Timing: Prior to administration and continuously during rapid infusion
Rationale: To assess kidney function, as calcium is primarily renally excreted and renal impairment can affect calcium levels.
Timing: Prior to administration
Rationale: To establish baseline and monitor response to treatment.
Timing: Prior to administration
Rationale: To establish baseline and monitor response to treatment.
Timing: Prior to administration
Routine Monitoring
Frequency: Every 4-6 hours initially, then daily or as clinically indicated, especially in continuous infusions.
Target: Total: 8.5-10.5 mg/dL; Ionized: 1.12-1.32 mmol/L
Action Threshold: Adjust dose if levels are outside target range or if symptoms of hypo/hypercalcemia occur.
Frequency: Continuous during rapid infusion; periodically during maintenance infusions.
Target: Normal sinus rhythm, absence of arrhythmias or conduction abnormalities.
Action Threshold: Bradycardia, arrhythmias, QT interval changes, or widening QRS complex require immediate intervention.
Frequency: Every 15-30 minutes during infusion, then every 1-4 hours.
Target: Within patient's normal limits.
Action Threshold: Significant changes (e.g., hypotension, bradycardia) may indicate adverse reaction.
Frequency: Regularly during infusion.
Target: No signs of redness, swelling, pain, or extravasation.
Action Threshold: Signs of extravasation require immediate discontinuation and management.
Symptom Monitoring
- Signs of hypercalcemia (nausea, vomiting, constipation, polyuria, polydipsia, muscle weakness, confusion, lethargy, cardiac arrhythmias)
- Signs of hypocalcemia (tetany, paresthesias, muscle cramps, seizures, Chvostek's sign, Trousseau's sign)
- Signs of extravasation (pain, swelling, redness at injection site)
- Cardiac rhythm changes (bradycardia, arrhythmias)
Special Patient Groups
Pregnancy
Pregnancy Category C. Calcium is an essential nutrient. While calcium gluconate is used to treat acute, life-threatening conditions, its use should be carefully weighed against potential risks. Animal reproduction studies have not been conducted. Use only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Calcium is a normal component of breast milk. While calcium gluconate is excreted into breast milk, the amount is unlikely to cause adverse effects in a breastfed infant when administered acutely. Use with caution, but generally considered compatible with breastfeeding.
Pediatric Use
Dosing is weight-based (mg/kg). Careful calculation and slow administration are crucial to avoid hypercalcemia and cardiac adverse effects. Close monitoring of heart rate, ECG, and serum calcium levels is essential, especially in neonates and infants due to immature renal function and smaller fluid volumes.
Geriatric Use
Use with caution due to potential for age-related decreases in renal function, which can affect calcium excretion. Increased risk of hypercalcemia. Start with lower doses and monitor serum calcium and renal function closely. More susceptible to adverse cardiac effects, especially if on digoxin.
Clinical Information
Clinical Pearls
- Administer IV calcium gluconate slowly (typically over 5-10 minutes) to minimize the risk of hypotension, bradycardia, and cardiac arrhythmias.
- Calcium gluconate is less irritating to veins than calcium chloride but still carries a risk of extravasation. Administer via a large peripheral vein or central line. Avoid intramuscular or subcutaneous injection due to risk of tissue necrosis and abscess formation.
- Do NOT mix calcium gluconate with bicarbonate or phosphate solutions in the same IV line or syringe, as precipitation will occur.
- Always monitor ECG during rapid IV administration, especially in patients receiving digoxin, as calcium can potentiate digoxin toxicity.
- Correct hypomagnesemia before attempting to correct hypocalcemia, as magnesium is required for parathyroid hormone secretion and action.
- Calcium gluconate provides 90 mg (4.5 mEq) of elemental calcium per 1 gram (10 mL of 10% solution), whereas calcium chloride provides 270 mg (13.6 mEq) of elemental calcium per 1 gram (10 mL of 10% solution). Be mindful of the elemental calcium content when switching between salts.
Alternative Therapies
- Calcium Chloride Injection (provides more elemental calcium per gram, but is more irritating to veins and carries a higher risk of extravasation and tissue necrosis)
- Oral calcium supplements (for chronic hypocalcemia, not acute emergencies)
- Vitamin D analogs (for chronic hypocalcemia related to vitamin D deficiency)
- Magnesium sulfate (for magnesium deficiency, which can cause refractory hypocalcemia)
- Insulin/Dextrose, Beta-agonists, Sodium Bicarbonate (for hyperkalemia, as they shift potassium intracellularly, unlike calcium which stabilizes the cardiac membrane)